{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:41:40Z","timestamp":1775634100587,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"McKinsey"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Population-level data have suggested that bacille Calmette-Guerin (BCG) vaccination may lessen the severity of Coronavirus Disease-19 (COVID-19) prompting clinical trials in this area. Some reports have demonstrated conflicting results. We performed a robust, ecologic analysis comparing COVID-19 related mortality (CRM) between strictly selected countries based on BCG vaccination program status utilizing publicly available databases and machine learning methods to define the association between active BCG vaccination programs and CRM. Validation was performed using linear regression and country-specific modeling. CRM was lower for the majority of countries with a BCG vaccination policy for at least the preceding 15\u00a0years (BCG15). CRM increased significantly for each increase in the percent population over age 65. A higher total population of a country and BCG15 were significantly associated with improved CRM. There was a consistent association between countries with a BCG vaccination for the preceding 15\u00a0years, but not other vaccination programs, and CRM. BCG vaccination programs continued to be associated with decreased CRM even for populations\u2009&lt;\u200940\u00a0years old where CRM events are less frequent.<\/jats:p>","DOI":"10.1038\/s41598-020-80787-z","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:24:12Z","timestamp":1610479452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The association of Coronavirus Disease-19 mortality and prior bacille Calmette-Guerin vaccination: a robust ecological analysis using unsupervised machine learning"],"prefix":"10.1038","volume":"11","author":[{"given":"Nathan A.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanya","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapnika","family":"Nag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacomo","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas El","family":"Turabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noshir","family":"Kaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney W.","family":"Zemmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul K.","family":"Hegarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"80787_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20, 533\u2013534. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"80787_CR2","doi-asserted-by":"publisher","first-page":"e0233410","DOI":"10.1101\/2020.03.27.20045807","volume":"15","author":"H-Y Wang","year":"2020","unstructured":"Wang, H.-Y. et al. The psychological distress and coping styles in the early stages of the 2019 coronavirus disease (COVID-19) epidemic in the general mainland Chinese population: A web-based survey. PLoS ONE 15, e0233410. https:\/\/doi.org\/10.1101\/2020.03.27.20045807 (2020).","journal-title":"PLoS ONE"},{"key":"80787_CR3","doi-asserted-by":"publisher","unstructured":"McKibbin, W. J. & Fernando, R. The global macroeconomic impacts of COVID-19: Seven scenarios. Centre for Applied Macroeconomica Analysis Working Paper No 19\/2020, https:\/\/doi.org\/https:\/\/doi.org\/10.2139\/ssrn.3547729 (2020).","DOI":"10.2139\/ssrn.3547729"},{"key":"80787_CR4","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2019.20153","volume":"323","author":"JM Sanders","year":"2020","unstructured":"Sanders, J. M., Monogue, M. L., Jodlowski, T. Z. & Cutrell, J. B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA 323, 1824\u20131836 (2020).","journal-title":"JAMA"},{"key":"80787_CR5","doi-asserted-by":"crossref","unstructured":"Dhama, K. et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum. Vaccines Immunother. 16(6), 1232\u20131238 (2020).","DOI":"10.1080\/21645515.2020.1735227"},{"key":"80787_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1054\/tuld.1999.0206","volume":"79","author":"T Oettinger","year":"1999","unstructured":"Oettinger, T., J\u00f8rgensen, M., Ladefoged, A., Hasl\u00f8v, K. & Andersen, P. Development of the Mycobacterium bovis BCG vaccine: Review of the historical and biochemical evidence for a genealogical tree. Tuber. Lung Dis. 79, 243\u2013250 (1999).","journal-title":"Tuber. Lung Dis."},{"key":"80787_CR7","doi-asserted-by":"publisher","first-page":"g4643","DOI":"10.1136\/bmj.g4643","volume":"349","author":"A Roy","year":"2014","unstructured":"Roy, A. et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: Systematic review and meta-analysis. BMJ Br. Med. J. 349, g4643. https:\/\/doi.org\/10.1136\/bmj.g4643 (2014).","journal-title":"BMJ Br. Med. J."},{"key":"80787_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","volume":"204","author":"P Aaby","year":"2011","unstructured":"Aaby, P. et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: Beneficial nnspecific effects in the nonatal period?. J. Infect. Dis. 204, 245\u2013252. https:\/\/doi.org\/10.1093\/infdis\/jir240 (2011).","journal-title":"J. Infect. Dis."},{"key":"80787_CR9","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester, R. J., van der Meijden, A. P. & Lamm, D. L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials. J. Urol. 168, 1964\u20131970 (2002).","journal-title":"J. Urol."},{"key":"80787_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJ Arts","year":"2018","unstructured":"Arts, R. J. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23, 89\u2013100 (2018).","journal-title":"Cell Host Microbe"},{"key":"80787_CR11","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","volume":"212","author":"J Leentjens","year":"2015","unstructured":"Leentjens, J. et al. BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: A randomized, placebo-controlled pilot study. J. Infect. Dis. 212, 1930\u20131938 (2015).","journal-title":"J. Infect. Dis."},{"key":"80787_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000355628","volume":"6","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis, J. et al. Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity. J. Innate Immun. 6, 152\u2013158. https:\/\/doi.org\/10.1159\/000355628 (2014).","journal-title":"J. Innate Immun."},{"issue":"2520","key":"80787_CR13","first-page":"30049","volume":"S2588\u20139311","author":"PK Hegarty","year":"2020","unstructured":"Hegarty, P. K., Sfakianos, J. P., Giannarini, G., DiNardo, A. R. & Kamat, A. M. COVID-19 and bacillus Calmette-Gu\u00e9rin: What is the link?. Eur. Urol. Oncol. S2588\u20139311(2520), 30049\u201330043 (2020).","journal-title":"Eur. Urol. Oncol."},{"key":"80787_CR14","doi-asserted-by":"crossref","unstructured":"Miller, A. et al. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: An epidemiological study. MedRxiv (2020).","DOI":"10.1101\/2020.03.24.20042937"},{"key":"80787_CR15","doi-asserted-by":"crossref","unstructured":"Sala, G. & Miyakawa, T. Association of BCG vaccination policy with prevalence and mortality of COVID-19. medRxiv (2020).","DOI":"10.1101\/2020.03.30.20048165"},{"key":"80787_CR16","unstructured":"Bruin, J. UCLA: Statistical Consulting Group. https:\/\/stats.idre.ucla.edu\/stata\/ado\/analysis\/ (2006)."},{"key":"80787_CR17","unstructured":"Hale, T., Petherick, A., Phillips, T. & Webster, S. Variation in government responses to COVID-19. Blavatnik School of Government Working Paper 31 (2020)."},{"key":"80787_CR18","first-page":"1","volume":"2014","author":"M Charrad","year":"2014","unstructured":"Charrad, M., Ghazzali, N., Boiteau, V. & Niknafs, A. Determining the number of clusters using NbClust package. MSDM 2014, 1 (2014).","journal-title":"MSDM"},{"key":"80787_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1473-3099(15)00400-4","volume":"16","author":"P Nguipdop-Djomo","year":"2016","unstructured":"Nguipdop-Djomo, P., Heldal, E., Rodrigues, L. C., Abubakar, I. & Mangtani, P. Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: A retrospective population-based cohort study. Lancet Infect. Dis 16, 219\u2013226 (2016).","journal-title":"Lancet Infect. Dis"},{"key":"80787_CR20","first-page":"1","volume":"17","author":"J Lord","year":"2013","unstructured":"Lord, J. et al. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: The Modelling Algorithm Pathways in Guidelines (MAPGuide) project. Health Technol. Assess. (Winchester, England) 17, 1\u2013192 (2013).","journal-title":"Health Technol. Assess. (Winchester, England)"},{"key":"80787_CR21","unstructured":"WHO-UNICEF. WHO vaccine-preventable diseases: monitoring system 2019 global summary. Geneva (CH): World Health Organization; 2019 https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragedtp3.html (2019)."},{"key":"80787_CR22","doi-asserted-by":"publisher","first-page":"9696","DOI":"10.1073\/pnas.2004911117","volume":"117","author":"JB Dowd","year":"2020","unstructured":"Dowd, J. B. et al. Demographic science aids in understanding the spread and fatality rates of COVID-19. Proc. Natl. Acad. Sci. 117, 9696\u20139698 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"80787_CR23","doi-asserted-by":"crossref","unstructured":"Redelman-Sidi, G. Could BCG be used to protect against COVID-19? Nat. Rev. Urol. 1\u20132 (2020).","DOI":"10.1038\/s41585-020-0325-9"},{"key":"80787_CR24","doi-asserted-by":"crossref","unstructured":"Shet, A., Ray, D., Malavige, N., Santosham, M. & Bar-Zeev, N. Differential COVID-19-attributable mortality and BCG vaccine use in countries. medRxiv (2020).","DOI":"10.1101\/2020.04.01.20049478"},{"key":"80787_CR25","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","volume":"382","author":"PK Bhatraju","year":"2020","unstructured":"Bhatraju, P. K. et al. Covid-19 in critically ill patients in the Seattle Region\u2014Case series. N. Engl. J. Med. 382, 2012\u20132022. https:\/\/doi.org\/10.1056\/NEJMoa2004500 (2020).","journal-title":"N. Engl. J. Med."},{"key":"80787_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.abb4218","volume":"368","author":"MUG Kraemer","year":"2020","unstructured":"Kraemer, M. U. G. et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science 368, 493\u2013497. https:\/\/doi.org\/10.1126\/science.abb4218 (2020).","journal-title":"Science"},{"key":"80787_CR27","doi-asserted-by":"crossref","unstructured":"Cohen, J. & Kupferschmidt, K. 1287\u20131288 (American Association for the Advancement of Science, 2020).","DOI":"10.1126\/science.367.6484.1287"},{"key":"80787_CR28","doi-asserted-by":"publisher","first-page":"18377","DOI":"10.1038\/s41598-020-75491-x","volume":"10","author":"J Hensel","year":"2020","unstructured":"Hensel, J. et al. Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses. Sci. Rep. 10, 18377 (2020).","journal-title":"Sci. Rep."},{"key":"80787_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8189","author":"U Hamiel","year":"2020","unstructured":"Hamiel, U., Kozer, E. & Youngster, I. SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults. JAMA https:\/\/doi.org\/10.1001\/jama.2020.8189 (2020).","journal-title":"JAMA"},{"issue":"30","key":"80787_CR30","doi-asserted-by":"publisher","first-page":"17720","DOI":"10.1073\/pnas.2008410117","volume":"117","author":"LE Escobar","year":"2020","unstructured":"Escobar, L. E., Molina-Cruz, A. & Barillas-Mury, C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc. Natl. Acad. Sci. 117(30), 17720\u201317726 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"80787_CR31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/lam.13365","volume":"71","author":"TM Wassenaar","year":"2020","unstructured":"Wassenaar, T. M., Buzard, G. S. & Newman, D. J. BCG vaccination early in life does not improve COVID-19 outcome of elderly populations, based on nationally reported data. Lett. Appl. Microbiol. 71(5), 498\u2013505 (2020).","journal-title":"Lett. Appl. Microbiol."},{"key":"80787_CR32","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1056\/NEJMc2001801","volume":"382","author":"J-Y Song","year":"2020","unstructured":"Song, J.-Y., Yun, J.-G., Noh, J.-Y., Cheong, H.-J. & Kim, W.-J. Covid-19 in South Korea\u2014challenges of subclinical manifestations. N. Engl. J. Med. 382, 1858\u20131859 (2020).","journal-title":"N. Engl. J. Med."},{"key":"80787_CR33","doi-asserted-by":"crossref","unstructured":"Mills, G., Cullen, W., Moore, N. & Foley, R. Making sense of publicly available data on COVID-19 in Ireland. medRxiv (2020).","DOI":"10.1101\/2020.05.13.20101089"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80787-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:02:38Z","timestamp":1670032958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80787-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80787"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80787-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"11 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The following authors report no conflicts of interest: NAB, AP, SG, SN, NK, RWZ, JC, AET, and PKH. AMK is a consultant for Merck & Co (Kenilworth, NJ, USA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"774"}}